Clinical Trial Update: TREatment of degeNerative and Neoplastic Diseases With Rituximab [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on treating diffuse large B-cell lymphoma with rituximab in Phase 2 and Phase 3, sponsored by Probiomed S.A. de C.V.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Probiomed S.A. de C.V. | Conditions: Diffuse Large B Cell Lymphoma | Phase 2, Phase 3 | Status: UNKNOWN